Managing elderly patients with glioblastoma presents a unique set of challenges, including
a scarcity of available data, which limits evidence-based recommendations. Nearly half of …

Glioblastoma is a highly malignant neoplasm, notorious for its poor prognosis. The median
age of diagnosis is 64 years, with an increasing number of patients diagnosed over the age …

Opinion statement Newly diagnosed elderly patients (age> 65–70 years) with glioblastoma
should be treated with a patient-centred approach by a multi-disciplinary team …

Opinion statement The number of patients over 65 with newly diagnosed glioblastoma is
anticipated to increase significantly in coming decades as a result of demographic shifts in …

Glioblastoma is the most common primary malignant brain tumor diagnosed in the USA and
is associated with a poor prognosis. The outcomes in elderly patients (more than 65 years of …

The optimal management of elderly patients with glioblastoma multiforme (GBM) remains
controversial, as no evidencebased standard of care exists for this unique subpopulation …

Glioblastoma is common among elderly patients, a group in which comorbidities and a poor
prognosis raise important considerations when designing neuro‐oncologic care. Although …

Glioblastoma in the elderly (> 65 years of age) is associated with shorter overall survival
(OS) than in younger patients. Best practice recommendations for elderly patients, especially …

Current treatment of glioblastoma in the elderly includes surgery, radiotherapy and
chemotherapy, but the prognosis remains extremely poor, and its optimal management is …

Glioblastoma, a WHO grade IV astrocytoma, is the most common primary malignant brain
tumor in adults. It is characterized by molecular heterogeneity and aggressive behavior …